| Accession Number | 0002010019-26-000030 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 3, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Oct 1, 2026 | Sale | 200 | $411.62 | $82,324.00 | 109,714 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Oct 1, 2026 | Sale | 954 | $413.11 | $394,103.70 | 108,760 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Oct 1, 2026 | Sale | 1,846 | $415.07 | $766,217.56 | 106,914 | Direct | โ | View Details |